HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Coal dust exposure and mortality from ischemic heart disease among a cohort of U.S. coal miners.

AbstractBACKGROUND:
Particulate exposure from air pollution increases the risk of ischemic heart disease (IHD) mortality. Although coal miners are highly exposed to coal dust particulate, studies of IHD mortality risk among coal miners have had inconsistent results. Previous studies may have been biased by the healthy worker effect.
METHODS:
We examined the dose-response relationship between cumulative coal dust exposure, coal rank, and IHD mortality among a cohort of underground coal miners who participated in the National Study of Coal Workers' Pneumoconiosis.
RESULTS:
After adjusting for age, smoking, and body mass index, risk of IHD mortality increased at higher levels of coal dust exposure. Mortality risk was also associated with coal rank region.
CONCLUSION:
There was an increased risk of mortality from IHD associated with cumulative exposure to coal dust, and with coal rank. The effect of coal rank may be due differences in the composition of coal mine dust particulate. The association of risk of IHD mortality with cumulative particulate exposure is consistent with air pollution studies.
AuthorsDeborah D Landen, James T Wassell, Linda McWilliams, Ami Patel
JournalAmerican journal of industrial medicine (Am J Ind Med) Vol. 54 Issue 10 Pg. 727-33 (Oct 2011) ISSN: 1097-0274 [Electronic] United States
PMID21761428 (Publication Type: Journal Article)
CopyrightCopyright © 2011 Wiley-Liss, Inc.
Chemical References
  • Air Pollutants, Occupational
  • Coal
  • Dust
  • Particulate Matter
Topics
  • Adult
  • Air Pollutants, Occupational (adverse effects)
  • Coal (adverse effects, classification)
  • Coal Mining
  • Dust
  • Humans
  • Middle Aged
  • Myocardial Ischemia (mortality)
  • Occupational Diseases (mortality)
  • Occupational Exposure (adverse effects)
  • Particulate Matter (adverse effects)
  • Risk Factors
  • United States (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: